Role of Lp A-I and Lp A-I/A-II in cholesteryl ester transfer protein- mediated neutral lipid transfer: Studies in normal subjects and in hypertriglyceridemic patients before and after fenofibrate therapy

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 11, 1996, Pages 1340-1346

  McPherson, Ruth ^a,d   Agnani, Geneviève ^b   Lau, Paulina ^a   Fruchart, Jean Charles ^b   Edgar, Alan D ^c   Marcel, Yves L ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b INSTITUT PASTEUR DE LILLE   (France)

^c Laboratoires Fournier   (France)

^d H453 ^*  (Canada)

Author keywords

apolipoprotein A I; apolipoprotein A II; cholesteryl ester transfer protein; fenofibrate; HDL

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; LIPID TRANSPORT; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0029861551     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.11.1340     Document Type: Article

References (31)

1. Puchois P, Kandoussis A, Fievet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 1987;68:35-40.
2. Barbaras R, Puchois P, Fruchart JC, Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by Lp A-I particles but not by Lp A-I/A-II particles. Biochem Biophys Res Commun. 1987;142:63-69.
3. Rader DJ, Castro G, Zech LA, Fruchart JC, Brewer HB. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles Lp A-I and Lp A-I/A-II. J Lipid Res. 1991;32:1849-1859.
4. Cheung MC, Wolf AC, Lum KD, Tollefson JH, Albers JJ. Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J Lipid Res. 1986;27:1135-1144.
5. Quinet EM, Huerta P, Nancoo D, Tall AR, Marcel YL, McPherson R. Regulation of cholesteryl ester transfer protein synthesis by probucol. J Lipid Res. 1993;34:845-852.
6. Benzie I. An evaluation of a routine assay of serum high density lipoprotein cholesterol using dextran sulphate and magnesium chloride. Clin Chem. 1979;36:289-291.
7. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay using ready-to-use plates for Lp A-I lipoprotein particles. Clin Chem. 1990;236:1431-1435.
8. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadski Z, Weech P, Whitlock ME, Tall AR, Milne RW. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest. 1990;85:10-17.
9. Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem. 1984;259:12201-12209.
10. Roberts DCK, Miller NE, Price SG, Crook D, Cortese C, LaVille A, Masana L, Lewis B. An alternative procedure for incorporating radiolabelled cholesteryl ester into human plasma lipoproteins in vitro. Biochem J. 1985;226:319-322.
11. Morton RE, Zilversmit DB. A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. J Biol Chem. 1981;256:11992-11995.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
13. Quinet EM, Agellon LB, Kroon PA, Marcel YL, Lee YC, Whitlock ME, Tall AR. Atherogenic diet increases cholesteryl ester transfer protein (CETP) mRNA levels in rabbit liver. J Clin Invest. 1990;85:357-363.
14. SAS Institute Inc. SAS/STAT User's Guide, Version 6.03. Cary, NC: SAS Institute Inc; 1988.
15. Descamps O, Bilheimer D, Herz J. Insulin stimulates receptor-mediated uptake of apoE-rich lipoproteins and activated α2-macroglobulin in adipocytes. J Biol Chem. 1993;268:974-981.
16. Drexel H, Amann FW, Beran J, Rentsch K, Candinas R, Muntwyler J, Luethy A, Gasser T, Follath F. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of atherosclerosis. Circulation. 1994;90:2230-2235.
17. Knopp RH, Walden CE, Warnick GR. Effects of fenofibrate treatment on plasma lipoprotein lipids, high density lipoprotein cholesterol subfractions and apolipoprotein B, A-I, A-II and E. Am J Med. 1987;83(suppl 5B):75-84.
18. Fruchart JC, Davignon J, Bard JM, Grothe AM, Richard A, Fievet C. Effect of fenofibrate treatment on type III hyperlipoproteinemia. Am J Med. 1987;83(suppl 5B):71-74.
19. Radeau T, Lau P, McDonnell M, Robb M, Ailhaud G, McPherson R. Cholesteryl ester transfer protein mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content. J Lipid Res. 1995;36:2552-2561.
20. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb. 1991;11:797-804.
21. Mann CJ, Yen FT, Grant AM, Bihain B. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 1991;88:2059-2066.
22. Mowri HO, Patsch JR, Ritsch A, Föger B, Brown S, Patsch W. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein and activities of lipoprotein lipase, hepatic lipase and lecithin:cholesterol acyltransferase. J Lipid Res. 1994;35:291-300.
23. Morton RE. Binding of plasma-derived lipid transfer protein to lipoprotein substrates: the role of binding in the lipid transfer process. J Biol Chem. 1985;260:12593-12599.
24. Francone OL, Guraker A, Fielding C. Distribution and function of lecithin cholesteryl:acyl transferase and lipid transfer protein in plasma lipoproteins. J Biol Chem. 1989;264:7066-7072.
25. Wang S, Deng L, Milne RA, Tall AR. Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing monoclonal antibody and necessary for neutral lipid transfer activity. J Biol Chem. 1992;267:17487-17490.
26. Wang S, Wang X, Deng L, Rassart E, Milne RW, Tall AR. Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein: opposite faces of amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody. J Biol Chem. 1993;268:1955-1959.
27. Moulin P, Cheung MC, Brace C, Zhong S, Cocke T, Richardson H, Tall AR. Gender effects on the distribution of the cholesteryl ester transfer protein in apolipoprotein A-I-defined lipoprotein subpopulations. J Lipid Res. 1994;35:793-802.
28. Rye KA, Garrety KH, Barter PJ. Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: the role of apolipoproteins. J Lipid Res. 1992;33:215-224.
29. McPherson R, Lau P, Tall A. Plasma kinetics of cholesteryl ester transfer protein in the rabbit: effects of dietary cholesterol. Circulation. 1995;92(suppl I):I-496-I-497.
30. Ohnishi T, Tan C. Yokoyama S. Selective transfer of cholesteryl ester over triglyceride by human plasma lipid protein between apolipoprotein-activated lipid microemulsions. Biochemistry. 1994;33:4533-4542.
31. Epps DE, Greenlee KA, Harris JS, Thomas EW, Castle CK, Fisher JF, Hozak RR, Marschke CK, Melchior GW, Kezdy FJ. Kinetics and inhibition of lipid exchange catalyzed by plasma cholesteryl ester transfer protein (lipid transfer protein). Biochemistry. 1995;34:12560-12569.